J4 ›› 2013, Vol. 26 ›› Issue (2): 41-47.doi: 10.3976/j.issn.1002-4026.2013.02.008

• Article • Previous Articles     Next Articles

Soluble expression and purification of GnRHPE39KDEL and the inhibition to the activity of a tumor cell

 GUO Kai, ZHAO Xiao-Yan, ZHOU Hong-Zi, CHEN Kai, LI Ji-Shun, CHEN Quan, YANG He-Tong   

  1. Shandong Provincial Key Laboratory of Applied Microorganism, Biotechnology Center, Shandong Academy of Sciences, Jinan 250014, China
  • Received:2012-12-07 Published:2013-04-20 Online:2013-04-20

Abstract:

We obtained fulllength nucleic acid sequence of an recombinant immunotoxin of GnRH and PE39KDEL by gene synthesis based on the E. coli codon bias. Factor Xa restriction site was inserted at the C termanol of GnRHPE39KDEL to obtion pET24bGnRHPE39KDEL recombinated plasmid which was then converted into E. coli BL21 (DE3) and BL21 (DE3) plyS. Results show that recombinant immunotoxin exhibits highlevel soluble expression after 0.2 mmol/L IPTG induction at 30 ℃ for 2 h in LB media with 0.2 % glucose till OD600 is acquired at 37 ℃ for about 0.6 h. The purity of fusion protein is above 95% and the protein yield is about 2.6 mg/g after sonication, highspeed centrifugation, HisTrap column purification and desalt. IC-50 detection indicates that the recombinant protein can significantly inhibit the growth of tumor cell strains.

Key words: GnRH, PE39KDEL, soluble expression, expression strain

CLC Number: 

  • Q753

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits third parties to freely share (i.e., copy and redistribute the material in any medium or format) and adapt (i.e., remix, transform, or build upon the material) the articles published in this journal, provided that appropriate credit is given, a link to the license is provided, and any changes made are indicated. The material may not be used for commercial purposes. For details of the CC BY-NC 4.0 license, please visit: https://creativecommons.org/licenses/by-nc/4.0